Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wilson Alexander Blair, holds the title of CLO, CSO and Corp Secretary at AEON Biopharma, Inc..
On 2026-11-20, the insider transacted 135,706 shares.The shares were transacted at a weighted average price of $0.13 per share, resulting in a total market-relevant value of $17K.
Wilson Alexander Blair (CLO, CSO and Corp Secretary) bought $17K of $AEON
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.